Literature DB >> 7992853

Detection of human herpesvirus 6 and human papillomavirus 16 in cervical carcinoma.

M Chen1, H Wang, C D Woodworth, P Lusso, Z Berneman, D Kingma, G Delgado, J A DiPaolo.   

Abstract

A subset of human papillomaviruses (HPVs) is associated with the majority of cervical cancers; however, cofactors appear to be required for carcinogenic progression of HPV-induced neoplasia. As human herpesvirus-6 (HHV-6) was recently shown to infect cervical epithelial cells in vitro and activate transcription of HPV-transforming genes, human cervical dysplasia and cancers were analyzed for the presence of HHV-6 by multiple methods, including polymerase chain reaction, slot blot, Southern blot, and in situ hybridization. HHV-6 DNA sequences were detected in 6 of 72 cases of squamous cervical carcinoma and cervical intraepithelial neoplasia. HPV-16 was found in four of the HHV-6-positive cases (two squamous cervical carcinomas and two cervical intraepithelial neoplasias). None of the 30 normal cervices and biopsies of patients with cervicitis was positive for HHV-6 DNA. These results are the first suggestion of an in vivo association between HHV-6 and some cervical neoplasia.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7992853      PMCID: PMC1887479     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  32 in total

1.  Chromosome observations on three epithelial-cell cultures derived from carcinomas of the human cervix.

Authors:  N AUERSPERG; A P HAWRYLUK
Journal:  J Natl Cancer Inst       Date:  1962-03       Impact factor: 13.506

2.  RNA detection and localization in cells and tissue sections by in situ hybridization of 35S-labeled RNA probes.

Authors:  M E Harper; L M Marselle
Journal:  Methods Enzymol       Date:  1987       Impact factor: 1.600

3.  Identification of human herpesvirus 6-specific DNA sequences in two patients with non-Hodgkin's lymphoma.

Authors:  R F Jarrett; S Gledhill; F Qureshi; S H Crae; R Madhok; I Brown; I Evans; A Krajewski; C J O'Brien; R A Cartwright
Journal:  Leukemia       Date:  1988-08       Impact factor: 11.528

4.  Age prevalence of antibody to human herpesvirus 6.

Authors:  M Briggs; J Fox; R S Tedder
Journal:  Lancet       Date:  1988-05-07       Impact factor: 79.321

5.  Papillomavirus sequences integrate near cellular oncogenes in some cervical carcinomas.

Authors:  M Dürst; C M Croce; L Gissmann; E Schwarz; K Huebner
Journal:  Proc Natl Acad Sci U S A       Date:  1987-02       Impact factor: 11.205

6.  Detection of human B-lymphotropic virus (human herpesvirus 6) sequences in B cell lymphoma tissues of three patients.

Authors:  S F Josephs; A Buchbinder; H Z Streicher; D V Ablashi; S Z Salahuddin; H G Guo; F Wong-Staal; J Cossman; M Raffeld; J Sundeen
Journal:  Leukemia       Date:  1988-03       Impact factor: 11.528

7.  Identification of human herpesvirus-6 as a causal agent for exanthem subitum.

Authors:  K Yamanishi; T Okuno; K Shiraki; M Takahashi; T Kondo; Y Asano; T Kurata
Journal:  Lancet       Date:  1988-05-14       Impact factor: 79.321

8.  Isolation of a new virus, HBLV, in patients with lymphoproliferative disorders.

Authors:  S Z Salahuddin; D V Ablashi; P D Markham; S F Josephs; S Sturzenegger; M Kaplan; G Halligan; P Biberfeld; F Wong-Staal; B Kramarsky
Journal:  Science       Date:  1986-10-31       Impact factor: 47.728

9.  Introduction of human chromosome 11 via microcell transfer controls tumorigenic expression of HeLa cells.

Authors:  P J Saxon; E S Srivatsan; E J Stanbridge
Journal:  EMBO J       Date:  1986-12-20       Impact factor: 11.598

10.  In vitro cellular tropism of human B-lymphotropic virus (human herpesvirus-6).

Authors:  P Lusso; P D Markham; E Tschachler; F di Marzo Veronese; S Z Salahuddin; D V Ablashi; S Pahwa; K Krohn; R C Gallo
Journal:  J Exp Med       Date:  1988-05-01       Impact factor: 14.307

View more
  9 in total

Review 1.  Human herpesvirus 6.

Authors:  D K Braun; G Dominguez; P E Pellett
Journal:  Clin Microbiol Rev       Date:  1997-07       Impact factor: 26.132

Review 2.  Update on human herpesvirus 6 biology, clinical features, and therapy.

Authors:  Leen De Bolle; Lieve Naesens; Erik De Clercq
Journal:  Clin Microbiol Rev       Date:  2005-01       Impact factor: 26.132

3.  Infection and cervical neoplasia: facts and fiction.

Authors:  Wael I Al-Daraji; John Hf Smith
Journal:  Int J Clin Exp Pathol       Date:  2008-04-28

4.  Chlamydia trachomatis infection induces replication of latent HHV-6.

Authors:  Bhupesh K Prusty; Christine Siegl; Petra Hauck; Johannes Hain; Suvi J Korhonen; Eija Hiltunen-Back; Mirja Puolakkainen; Thomas Rudel
Journal:  PLoS One       Date:  2013-04-19       Impact factor: 3.240

Review 5.  Human Herpesvirus 6 and Malignancy: A Review.

Authors:  Eva Eliassen; Emily Lum; Joshua Pritchett; Joseph Ongradi; Gerhard Krueger; John R Crawford; Tuan L Phan; Dharam Ablashi; Stanley David Hudnall
Journal:  Front Oncol       Date:  2018-11-13       Impact factor: 6.244

Review 6.  Human Herpesviruses 6A and 6B in Reproductive Diseases.

Authors:  Anthony L Komaroff; Roberta Rizzo; Jeffrey L Ecker
Journal:  Front Immunol       Date:  2021-03-25       Impact factor: 7.561

7.  DeepVISP: Deep Learning for Virus Site Integration Prediction and Motif Discovery.

Authors:  Haodong Xu; Peilin Jia; Zhongming Zhao
Journal:  Adv Sci (Weinh)       Date:  2021-03-08       Impact factor: 16.806

8.  Relapses of primary cutaneous anaplastic large-cell lymphoma in a female immunocompetent patient with persistent chlamydophila pneumoniae and human herpesvirus 8 infection.

Authors:  Elisabetta Caselli; Alessandro Borghi; Martina Maritati; Roberta Gafà; Giovanni Lanza; Dario Di Luca; Annarosa Virgili; Carlo Contini
Journal:  Infect Agent Cancer       Date:  2016-07-05       Impact factor: 2.965

9.  Presence of HHV-6A in Endometrial Epithelial Cells from Women with Primary Unexplained Infertility.

Authors:  Roberto Marci; Valentina Gentili; Daria Bortolotti; Giuseppe Lo Monte; Elisabetta Caselli; Silvia Bolzani; Antonella Rotola; Dario Di Luca; Roberta Rizzo
Journal:  PLoS One       Date:  2016-07-01       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.